ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,363.295
0.13%
Brent Oil
82.355
-0.04%
Bitcoin
61,456.50
0.01%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Invitae Corporation (NVTA)

  7. Invitae Corporation (NVTA) News

Invitae (NVTA)

Invitae Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NVTA
DateTimeSourceHeadlineSymbolCompany
06/03/202413:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
06/02/202422:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
30/01/202412:00PR Newswire (US)Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsNYSE:NVTAInvitae Corporation
29/01/202421:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:NVTAInvitae Corporation
24/01/202421:34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:NVTAInvitae Corporation
22/01/202412:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
22/01/202412:00PR Newswire (US)Invitae Completes Sale of Reproductive Health Assets to NateraNYSE:NVTAInvitae Corporation
18/01/202421:10Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
22/12/202302:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
22/12/202302:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
14/12/202321:29Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
13/12/202321:07PR Newswire (US)Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsNYSE:NVTAInvitae Corporation
11/12/202321:41Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
17/11/202321:48Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
15/11/202321:22Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
15/11/202300:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
15/11/202300:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
08/11/202321:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVTAInvitae Corporation
08/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
08/11/202321:01PR Newswire (US)Invitae Reports Third Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
06/11/202321:00PR Newswire (US)Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research PartnershipsNYSE:NVTAInvitae Corporation
01/11/202310:59PR Newswire (US)Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NYSE:NVTAInvitae Corporation
25/10/202316:00PR Newswire (US)Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive ResultsNYSE:NVTAInvitae Corporation
20/10/202323:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
19/10/202321:38Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
19/10/202321:30PR Newswire (US)Invitae Appoints Dr. David Sholehvar as Chief Operating OfficerNYSE:NVTAInvitae Corporation
12/10/202321:15PR Newswire (US)Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast CancerNYSE:NVTAInvitae Corporation
10/10/202321:30PR Newswire (US)Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical GenomicsNYSE:NVTAInvitae Corporation
03/10/202317:07PR Newswire (US)Invitae's Common Hereditary Cancers Panel Receives FDA Market AuthorizationNYSE:NVTAInvitae Corporation
03/10/202302:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
 Showing the most relevant articles for your search:NYSE:NVTA

Your Recent History

COIN
SRTUST
Smart Reward Token
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved